Search
Search Results
##search.searchResults.foundPlural##
-
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1797PDF: 799HTML: 10229Figures 1,2,3: 172 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
947PDF: 577HTML: 336 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1587PDF: 574HTML: 377 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3673PDF: 1233HTML: 3881Untitled: 207Untitled: 257 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1783Suppl. Files: 860HTML: 419PDF: 733 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2045PDF: 636HTML: 261 -
-
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1170PDF: 827HTML: 3358 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
827PDF: 1222HTML: 130 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1816PDF: 714HTML: 2101Untitled: 211Untitled: 151Untitled: 167Untitled: 152Untitled: 160Untitled: 175Untitled: 183 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
969PDF: 443HTML: 132 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4465PDF: 1914HTML: 17733 -
WHAT ARE FUNGAL INFECTIONS?
4160PDF: 2367HTML: 27593de Pauw: 235 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
944PDF: 1204HTML: 106 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3302PDF: 1463HTML: 3996 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3666PDF: 1433HTML: 181 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1556PDF: 769HTML: 1299 -
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2802PDF: 944HTML: 7330 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1095PDF: 485HTML: 8162 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2769PDF: 1011HTML: 360Preferred Reviewers: 204 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2086PDF: 985HTML: 4067Cover Letter: 219Figure 1: 229Figure 2: 228Table 1: 202 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2209PDF: 961HTML: 1890 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1352PDF: 1031HTML: 4601







